This is Thomas Sullivan's Typepad Profile.
Join Typepad and start following Thomas Sullivan's activity
Join Now!
Already a member? Sign In
Thomas Sullivan
Columbia, Maryland
Former political consultant who founded Rockpointe, Inc. a bio-medical education company in 1995.
Interests: marketing, politics, baseball, cycling, medicine, university of florida sports, medical education, track and cross country, driving kids to various practices
Recent Activity
Image
Medco Health Solutions Inc., a wholly-owned subsidiary of the pharmacy benefit manager Express Scripts Holding Company, has agreed to pay $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act, the... Continue reading
Posted 2 days ago at Policy and Medicine
Image
Today, May 21, the Open Payments 15-day data correction period begins for applicable manufactures and group purchasing organizations. The correction period will end June 5. During this time, applicable manufacturers and GPOs should acknowledge and resolve disputes initiated by physicians... Continue reading
Posted 2 days ago at Policy and Medicine
Image
This morning, the House Energy and Commerce Committee voted 51-0 to approve the 21st Century Cures Act. With the way the bipartisan bill sailed through, it appears the 21st Century Cures train has left the station. The Act was authored... Continue reading
Posted 3 days ago at Policy and Medicine
Image
Almost like clockwork, the Food and Drug Administration’s Office of Prescription Drug Promotion (OPDP) has released its fifth enforcement letter of 2015—they have issued one letter in January, February, March, April, and now, as of the past week, one in... Continue reading
Posted 3 days ago at Policy and Medicine
Image
Hospital Compare is, according to CMS, a “consumer-oriented website that provides information on how well hospitals provide care to their patients.” The website relies on data gleaned from the Hospital Consumer Assessment of Healthcare Providers and Systems, or HCAHPS, survey,... Continue reading
Posted 4 days ago at Policy and Medicine
Image
Lisa Rosenbaum, MD recently published an article entitled “Reconnecting the Dots—Reinterpreting Industry-Physician Relations,” in The New England Journal of Medicine. Rosenbaum’s article provides a refreshingly balanced analysis of financial conflicts of interest in medicine. “Although most observers agree that we... Continue reading
Posted 5 days ago at Policy and Medicine
Image
New York is the latest state to introduce a “pharmaceutical cost transparency act,” following five others—California, Oregon, Massachusetts, North Carolina, and Pennsylvania. Like the bills before it, New York would require pharmaceutical manufacturers to submit a report to the state... Continue reading
Posted 6 days ago at Policy and Medicine
Image
The Open Payments database lists most transfers of value made by pharmaceutical and device manufacturers to physicians and teaching hospitals, from a $10 sandwich to consulting arrangements in the thousands of dollars. The government database allows for users to search... Continue reading
Posted May 15, 2015 at Policy and Medicine
Image
Biosimilars 20/20 will take place from June 3 – 4 in Philadelphia, PA. The two-day conference is presented by the Specialty Pharma Education Center (SPEC) in partnership with the Specialty Pharma Journal (SPJ), and will offer a host of important... Continue reading
Posted May 15, 2015 at Policy and Medicine
Image
The Medical Device Tax, instituted as part of the Affordable Care Act, is a tax of 2.3 percent on the sale price of medical device products. There has been considerable pushback against the tax—with members of Congress from both sides... Continue reading
Posted May 14, 2015 at Policy and Medicine
Image
District Court Judge Jorge Alonso of the Northern District of Illinois recently dismissed the City of Chicago’s lawsuit against four out of five pharmaceutical manufacturers that the city accused of marketing opioids in violation of Illinois’ consumer fraud laws and... Continue reading
Posted May 13, 2015 at Policy and Medicine
Image
ExL Pharma's 6th Aggregate Spend and Sunshine Act Conference will take place on June 8-9 in Philadelphia, PA. The conference has an impressive array of speakers and presentations that promise to offer important insight into Open Payments requirements and shed... Continue reading
Posted May 13, 2015 at Policy and Medicine
Image
The Sunshine Act in the United States is but one physician payment disclosure obligation for manufacturers of drugs and devices to keep track of. We recently wrote about Medicines Australia’s transparency code; additionally, the European Federation of Pharmaceutical Industries and... Continue reading
Posted May 12, 2015 at Policy and Medicine
Image
2015 could prove to be a significant year for how the Food and Drug Administration approaches drug companies’ off-label speech. FDA has stressed that they are in the process of attempting to “harmonize” their promotional guidances with the First Amendment,... Continue reading
Posted May 11, 2015 at Policy and Medicine
Image
Long a champion of physician and industry collaboration, Thomas Stossel, M.D., has published a new book entitled Pharmaphobia: How the Conflict of Interest Myth Undermines American Medical Innovation. In it, Stossel, a distinguished Harvard hematologist and researcher, decries the conflict... Continue reading
Posted May 8, 2015 at Policy and Medicine
Image
In an effort to curtail the rise in Medicare cost, the Affordable Care Act established the Independent Payment Advisory Board (IPAB), which would consist of 15 presidentially appointed members tasked with proposing Medicare cuts if spending growth exceeded certain inflation-based... Continue reading
Posted May 7, 2015 at Policy and Medicine
Image
On April 24, 2015, the Australian Competition Consumer Commission (ACCC) granted authorization of Edition 18 of the industry trade group, Medicines Australia’s, Code of Conduct. If Medicines Australia members accept the authorization and the conditions, Edition 18 will come into... Continue reading
Posted May 6, 2015 at Policy and Medicine
Image
Last month, we launched our newest publication, Life Science Compliance Update. Each issue delivers in-depth analysis of important compliance issues for both pharmaceutical and device companies and those who serve that industry, with input from top compliance officers and healthcare... Continue reading
Posted May 6, 2015 at Policy and Medicine
Image
*CME Providers may now use hyperlinks to link to disclosure information *Also, starting May 1: All commercial logos must be removed from educational materials and disclosures in accordance with last year's decision The Accreditation Council for Continuing Medical Education (ACCME)... Continue reading
Posted May 5, 2015 at Policy and Medicine
Image
Last week, the owner of a durable medical equipment (DME) supply company was sentenced to 6 ½ years in prison for her role in submitting more than $7 million in fraudulent claims to Medicare. Adeline Ekwebelem’s Los Angeles-based DME company,... Continue reading
Posted May 4, 2015 at Policy and Medicine
Image
The Centers for Medicare and Medicaid Services (CMS) has added a new ream of physician data to its list: Medicare Part D prescription data. The huge data set—which details millions of individual claims totaling $103.7 billion that Medicare's Part D... Continue reading
Posted May 1, 2015 at Policy and Medicine
Image
Notable updates to January's Draft include bipartisan concessions: New provisions to increase NIH funding; removal of provisions for increased exclusivity periods. Today, the House Energy and Commerce Committee released an updated discussion draft of 21st Century Cures legislation (view the... Continue reading
Posted Apr 29, 2015 at Policy and Medicine
Image
On April 6, the Centers for Medicare and Medicaid Services (CMS) opened the review and dispute period, during which healthcare providers can log-in to Open Payments and review the payments attributed to them. Originally, CMS announced on April 6, 2015... Continue reading
Posted Apr 29, 2015 at Policy and Medicine
Image
Connecticut recently passed a law requiring manufacturers to report their transfers of value made to advance practice registered nurses (APRNs) practicing in Connecticut. This group includes nurse practitioners, clinical nurse specialists, nurse anesthetists, and nurse midwives. APRNs are excluded from... Continue reading
Posted Apr 28, 2015 at Policy and Medicine
Image
Yesterday, the Food and Drug Administration (FDA) announced the filing of a consent decree with Medtronic and two executives “for repeatedly failing to correct violations” related to the manufacture of Synchromed II Implantable Infusion Pump Systems, a medical device for... Continue reading
Posted Apr 28, 2015 at Policy and Medicine